2012 cervical cancer screening guidelines and the future role of HPV testing

Clinical Obstetrics and Gynecology

Volumn 56, Issue 1, 2013, Pages 44-50

  Priebe, Anna M ^a  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

Author keywords

cervical cancer; cervical intraepithelial neoplasia; human papillomavirus; screening guidelines

Indexed keywords

CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CONFERENCE PAPER; FEMALE; FUTUROLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRACTICE GUIDELINE; PREVALENCE; RISK ASSESSMENT; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRAL CLEARANCE; VIRAL TROPISM; VIRUS DETECTION; VIRUS GENOME; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84873411140     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e3182836b6a     Document Type: Conference Paper

References (20)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer JClin. 2011;61:69-90.
2. Siegel R, Naishadham D, Jemal A. Cancer sta-tistics, 2012. CA Cancer J Clin. 2012;62:10-29.
3. Saslow D, Solomon D, Lawson HW, et al. Amer-ican Cancer Society, American Society for Colpo-scopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147-172.
4. Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880-891.
5. De Villiers EM, Fauquet C, Broker TR, et al. Classification ofpapillomaviruses. Virology. 2004; 324:17-27.
6. Munoz N, Castellsague X, de Gonzalez AB, et al. HPV in the etiology of human cancer. Vaccine. 2006;24:S1-10.
7. Coutlee F, Ratnam S, Ramanakumar AV, et al. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. J Med Virol. 2011;83: 1034-1041.
8. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cer-vical cancer. J Clin Pathol. 2002;55:244-265.
9. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
10. Munoz N, Bosch FX, de Sanjose S, et al. Epide-miologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
11. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121:621-632.
12. Herrero R, Castle PE, Schiffman M, et al. Epi-demiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. JInfect Dis. 2005;191: 1796-1807.
13. Ho GY, Bierman R, Beardsley L, et al. Natural history ofcervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338: 423-428.
14. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. JInfect Dis. 1999;180:1415-1423.
15. Kjaer SK, van den Brule AJ, Paull G, et al. Type specific persistence of high risk human papillo-mavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ. 2002;325:572.
16. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papa-nicolaou screening tests for cervical cancer. NEngl JMed. 2007;357:1579-1588.
17. Naucler P, Ryd W, Tornberg S, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007;357: 1589-1597.
18. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus DNA testing for the de-tection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007; 370:1764-1772.
19. Dillner J, Rebolj M, Birembaut P, et al. Long term predictive values of cytology and human papillo-mavirus testing in cervical cancer screening: joint European cohort study. BMJ. 2008;337:a1754.
20. Castle PE, Stoler MH, Wright TC Jr, et al. Per-formance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol. 2011;12:880-890.